Trial Information
Real-Time MV/kV Image Guided Radiation Therapy
Inclusion Criteria:
- The study population will be drawn from available patient population that will be
treated using IMRT/VMAT. The Stanford population of IMRT/VMAT will be taken as
roughly representative of prospective IMRT patients and will not be subdivided by any
additional characteristics.
Exclusion Criteria:
- The study population will be drawn from available patient population that will be
treated using IMRT/VMAT. The Stanford population of IMRT/VMAT will be taken as
roughly representative of prospective IMRT patients and will not be subdivided by any
additional characteristics.
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
To verify improved tumor targeting accuracy using IMRT (intensity modulated radiation therapy) and VMAT (volumetric modulated radiation therapy)
Outcome Time Frame:
2 years
Safety Issue:
No
Principal Investigator
Lei Xing
Investigator Role:
Principal Investigator
Investigator Affiliation:
Stanford University
Authority:
United States: Institutional Review Board
Study ID:
SU-12132010-7282
NCT ID:
NCT01260909
Start Date:
May 2011
Completion Date:
May 2012
Related Keywords:
- Prostate Cancer
- Prostatic Neoplasms
Name | Location |
Stanford University School of Medicine |
Stanford, California 94305-5317 |